Palle Christophersen - Saniona AB Co-Founder and Chief Scientific Officer

SANION Stock  SEK 1.78  0.02  1.11%   

Founder

Dr. Palle Christophersen, Ph.D. has served as Chief Scientific Officer at Saniona AB since 2014. He is also CoFounder of the Company. He joined NeuroSearch in 1991 as Research Scientist in electrophysiology and served as project manager from 1994, where he developed the NeuroPatch system and discovered Endovion for sickle cell anaemia and cancer. From 20042011, he served as Director of In Vitro Pharmacology, and was in 2006 appointed Vice President and member of the NeuroSearch VP management group. He has authored more than 60 peerreviewed articles and is inventor of more than 60 patents. He is Chief Scientific Officer at Saniona AS. He holds a Doctorate in Philosophy in Physiology from the University of Copenhagen. since 2014.
Age 58
Tenure 10 years
Professional MarksPh.D
Phone45 70 70 52 25
Webhttps://www.saniona.com

Saniona AB Management Efficiency

The company has return on total asset (ROA) of (0.5044) % which means that it has lost $0.5044 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3844) %, meaning that it generated substantial loss on money invested by shareholders. Saniona AB's management efficiency ratios could be used to measure how well Saniona AB manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 92.97 M in total debt with debt to equity ratio (D/E) of 34.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Saniona AB has a current ratio of 1.26, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Saniona AB until it has trouble settling it off, either with new capital or with free cash flow. So, Saniona AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Saniona AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Saniona to invest in growth at high rates of return. When we think about Saniona AB's use of debt, we should always consider it together with cash and equity.
Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 21 people. Saniona AB (SANION) is traded on Stockholm Exchange in Sweden and employs 25 people.

Management Performance

Saniona AB Leadership Team

Elected by the shareholders, the Saniona AB's board of directors comprises two types of representatives: Saniona AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saniona. The board's role is to monitor Saniona AB's management team and ensure that shareholders' interests are well served. Saniona AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saniona AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Sundberg, Independent Director
Leif Andersson, Independent Director
Edward Saltzman, Director
Claus Braestrup, Independent Chairman of the Board
Palle Christophersen, Co-Founder and Chief Scientific Officer
Janus Larsen, Chief Officer
deBethizy, Chairman of the Board
MBA MSc, CoFounder CEO
Thomas Feldthus, CFO, Executive Vice President
Joergen Drejer, CEO, Director
Jorgen Drejer, Chairman Founder
Karin Nielsen, Chief Officer
Rami Levin, President
Anker Lundemose, Independent Director
Palle MS, Ex Research
Anita BCom, Chief Officer
Anna Ljung, Director

Saniona Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Saniona AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Saniona AB in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Saniona AB's short interest history, or implied volatility extrapolated from Saniona AB options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Saniona AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Saniona Stock analysis

When running Saniona AB's price analysis, check to measure Saniona AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Saniona AB is operating at the current time. Most of Saniona AB's value examination focuses on studying past and present price action to predict the probability of Saniona AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Saniona AB's price. Additionally, you may evaluate how the addition of Saniona AB to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Please note, there is a significant difference between Saniona AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Saniona AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Saniona AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.